AU465040B2 - A pharmaceutical composition useful as an anti-depressant agent an anti-parkinsonism agent - Google Patents
A pharmaceutical composition useful as an anti-depressant agent an anti-parkinsonism agentInfo
- Publication number
- AU465040B2 AU465040B2 AU45339/72A AU4533972A AU465040B2 AU 465040 B2 AU465040 B2 AU 465040B2 AU 45339/72 A AU45339/72 A AU 45339/72A AU 4533972 A AU4533972 A AU 4533972A AU 465040 B2 AU465040 B2 AU 465040B2
- Authority
- AU
- Australia
- Prior art keywords
- agent
- pharmaceutical composition
- composition useful
- parkinsonism
- depressant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
- C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17454871A | 1971-08-24 | 1971-08-24 | |
| US17495571A | 1971-08-25 | 1971-08-25 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU4533972A AU4533972A (en) | 1974-02-14 |
| AU465040B2 true AU465040B2 (en) | 1975-09-18 |
Family
ID=26870343
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU45339/72A Expired AU465040B2 (en) | 1971-08-24 | 1972-08-07 | A pharmaceutical composition useful as an anti-depressant agent an anti-parkinsonism agent |
Country Status (7)
| Country | Link |
|---|---|
| AU (1) | AU465040B2 (fr) |
| BE (1) | BE787908A (fr) |
| CA (1) | CA1017674A (fr) |
| DE (1) | DE2241473A1 (fr) |
| FR (1) | FR2150835B1 (fr) |
| GB (1) | GB1346405A (fr) |
| PH (1) | PH12325A (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4018912A (en) * | 1975-07-28 | 1977-04-19 | Ayerst Mckenna And Harrison Ltd. | Tripeptide derivatives with central nervous system activity and preparation thereof |
| US4623729A (en) * | 1982-07-22 | 1986-11-18 | E. R. Squibb & Sons, Inc. | Acylalkylaminocarbonyl substituted amino and imino acid compounds |
-
0
- BE BE787908D patent/BE787908A/fr unknown
-
1972
- 1972-08-01 CA CA148,436A patent/CA1017674A/en not_active Expired
- 1972-08-07 AU AU45339/72A patent/AU465040B2/en not_active Expired
- 1972-08-15 PH PH7213801A patent/PH12325A/en unknown
- 1972-08-22 GB GB3912572A patent/GB1346405A/en not_active Expired
- 1972-08-23 FR FR7230082A patent/FR2150835B1/fr not_active Expired
- 1972-08-23 DE DE19722241473 patent/DE2241473A1/de active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU4533972A (en) | 1974-02-14 |
| FR2150835A1 (fr) | 1973-04-13 |
| PH12325A (en) | 1979-01-16 |
| DE2241473A1 (de) | 1973-03-15 |
| FR2150835B1 (fr) | 1975-10-17 |
| BE787908A (fr) | 1973-02-23 |
| CA1017674A (en) | 1977-09-20 |
| GB1346405A (en) | 1974-02-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU482733B2 (en) | Pharmaceutical compositions | |
| AU472941B2 (en) | Pharmaceutical compositions | |
| CA974170A (en) | Pharmaceutical compositions | |
| AU475599B2 (en) | Pharmaceutical compositions | |
| ZA725283B (en) | A pharmaceutical composition useful as an anti-depressant agent an an anti-parkinsonism agent | |
| AU465040B2 (en) | A pharmaceutical composition useful as an anti-depressant agent an anti-parkinsonism agent | |
| AU476390B2 (en) | Pharmaceutical composition | |
| CA979730A (en) | Shortening composition | |
| AU5915973A (en) | Pharmaceutical compositions | |
| AU461136B2 (en) | Pharmaceutical composition | |
| CA1006816A (fr) | Compositions pharmaceutiques | |
| AU471794B2 (en) | Iodophor-steroid pharmaceutical compositions | |
| CA885421A (en) | Pharmaceutical composition | |
| CA884857A (en) | Pharmaceutical composition | |
| CA876689A (en) | Pharmaceutical compositions | |
| CA884860A (en) | Pharmaceutical compositions | |
| CA881476A (en) | Pharmaceutical compositions | |
| CA879074A (en) | Pharmaceutical compositions | |
| CA888155A (en) | Pharmaceutical compositions | |
| CA882088A (en) | Pharmaceutical compositions | |
| CA888688A (en) | Pharmaceutical compositions | |
| CA884856A (en) | Pharmaceutical compositions | |
| CA900357A (en) | Pharmaceutical composition | |
| AU478574B2 (en) | Pharmaceutical composition | |
| CA907518A (en) | Medicinal compositions |